Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults

Background: The anti-retroviral combination of abacavir/lamivudine plus rilpivirine (ABC/3TC/RPV) is not recommended by international guidelines as the first-line regimen. However, it is potent, well-tolerated, and affordable, especially in resource-limited settings. This study evaluates the efficac...

Full description

Bibliographic Details
Main Authors: Ho, Sharlene, Wong, Joshua Guoxian, Ng, Oon Tek, Lee, Cheng Chuan, Leo, Yee Sin, Lye, David Chien Boon, Wong, Chen Seong
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Journal Article
Language:English
Published: 2021
Subjects:
Science::Medicine
Abacavir
Rilpivirine
Online Access:https://hdl.handle.net/10356/148362

Similar Items

Similar Items